{"id":46169,"topic":"peptides","source":"TipRanks","title":"Hims & Hers rises after FDA advisers endorse broader BPC-157 access - TipRanks","url":"https://www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news","url_hash":"727535fc8e4eea46bf255943610ffa698273c2be","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMitgFBVV95cUxNckE1X2lXS0w2VE95S0FLZ3hQQkVuLVAzZjM1R24xS3BsQWdjZ0VKQ2x3QVhLNDJUOUxQODlVWG9mMl84ejl6VWgzbE8wOXB0eDg1NjkyeGFPalhxdHNuMlNzTTFxSWYxTWtVUXJKaTk2QkVlTmdXRFJTLTlQdk10OHJmY3hvNWpTYW9aUWotMldSR2NIUDRHa3lVajRlY1dpRzU4VElnN3VOTk1EWkhLS3QwMmJZQQ?oc=5\" target=\"_blank\">Hims & Hers rises after FDA advisers endorse broader BPC-157 access</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>","content":"Shares of Hims & Hers are climbing after a Food and Drug Administration advisory panel voted Thursday to add the peptide BPC-157 to a list that would permit broader pharmacy compounding. The vote came in at eight in favor, six against, with one abstention. Hims & Hers stock is up roughly 10%, trading around $34.78.\n- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions\n- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks\nPublished first on TheFly â the ultimate source for real-time, market-moving breaking financial news. Try Now>>\nRead More on HIMS:\n- Hims & Hers price target raised to $35 from $28 at Citi\n- Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 3.25%\n- Hims & Hers app downloads reverse 10 month decline, says Morgan Stanley\n- Hims & Hers Health Announces Accounting Officer Resignation\n- Hims & Hers chief accounting officer Irene Becklund to depart","image_url":"https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1110645284-750x406.jpg","lang":"en","published_at":"2026-07-23T17:13:58+00:00","fetched_at":"2026-07-25T22:15:09+00:00","status":"read","starred":0,"extract_state":"ok","summary_auto":"Shares of Hims & Hers are climbing after a Food and Drug Administration advisory panel voted Thursday to add the peptide BPC-157 to a list that would permit broader pharmacy compounding. The vote came in at eight in favor, six against, with one abstention.","cluster_id":null,"extract_retries":0,"extract_error":null,"contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 1024 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":1024,"summary_length":256,"usable_text_length":1024,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":1024,"summary_length":256}},"news_item":{"id":46169,"canonical_url":"https://www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news","source_url":"https://www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news","title":"Hims & Hers rises after FDA advisers endorse broader BPC-157 access - TipRanks","source_name":"TipRanks","author":null,"published_at":"2026-07-23T17:13:58+00:00","locale":"en","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMitgFBVV95cUxNckE1X2lXS0w2VE95S0FLZ3hQQkVuLVAzZjM1R24xS3BsQWdjZ0VKQ2x3QVhLNDJUOUxQODlVWG9mMl84ejl6VWgzbE8wOXB0eDg1NjkyeGFPalhxdHNuMlNzTTFxSWYxTWtVUXJKaTk2QkVlTmdXRFJTLTlQdk10OHJmY3hvNWpTYW9aUWotMldSR2NIUDRHa3lVajRlY1dpRzU4VElnN3VOTk1EWkhLS3QwMmJZQQ?oc=5\" target=\"_blank\">Hims & Hers rises after FDA advisers endorse broader BPC-157 access</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>","full_text":"Shares of Hims & Hers are climbing after a Food and Drug Administration advisory panel voted Thursday to add the peptide BPC-157 to a list that would permit broader pharmacy compounding. The vote came in at eight in favor, six against, with one abstention. Hims & Hers stock is up roughly 10%, trading around $34.78.\n- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions\n- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks\nPublished first on TheFly â the ultimate source for real-time, market-moving breaking financial news. Try Now>>\nRead More on HIMS:\n- Hims & Hers price target raised to $35 from $28 at Citi\n- Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 3.25%\n- Hims & Hers app downloads reverse 10 month decline, says Morgan Stanley\n- Hims & Hers Health Announces Accounting Officer Resignation\n- Hims & Hers chief accounting officer Irene Becklund to depart","excerpt":"Shares of Hims & Hers are climbing after a Food and Drug Administration advisory panel voted Thursday to add the peptide BPC-157 to a list that would permit broader pharmacy compounding. The vote came in at eight in favor, six against, with one abstention.","extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 1024 characters.","diagnostics_url":"/api/diagnose?url=https%3A//www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 1024 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":1024,"summary_length":256,"usable_text_length":1024,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":1024,"summary_length":256}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"Hims & Hers rises after FDA advisers endorse broader BPC-157 access - TipRanks","url":"https://www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news","summary":"Shares of Hims & Hers are climbing after a Food and Drug Administration advisory panel voted Thursday to add the peptide BPC-157 to a list that would permit broader pharmacy compounding. The vote came in at eight in favor, six against, with one abstention.","source":"TipRanks","date":"2026-07-23T17:13:58+00:00","content":"Shares of Hims & Hers are climbing after a Food and Drug Administration advisory panel voted Thursday to add the peptide BPC-157 to a list that would permit broader pharmacy compounding. The vote came in at eight in favor, six against, with one abstention. Hims & Hers stock is up roughly 10%, trading around $34.78.\n- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions\n- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks\nPublished first on TheFly â the ultimate source for real-time, market-moving breaking financial news. Try Now>>\nRead More on HIMS:\n- Hims & Hers price target raised to $35 from $28 at Citi\n- Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 3.25%\n- Hims & Hers app downloads reverse 10 month decline, says Morgan Stanley\n- Hims & Hers Health Announces Accounting Officer Resignation\n- Hims & Hers chief accounting officer Irene Becklund to depart","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 1024 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 1024 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":1024,"summary_length":256,"usable_text_length":1024,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":1024,"summary_length":256}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/46169","export_markdown":"/api/items/46169/export?format=markdown","export_json":"/api/items/46169/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news"},"formats":{"full":{"id":46169,"title":"Hims & Hers rises after FDA advisers endorse broader BPC-157 access - TipRanks","url":"https://www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news","source":"TipRanks","author":null,"published_at":"2026-07-23T17:13:58+00:00","locale":"en","topic":"peptides","tags":[],"excerpt":"Shares of Hims & Hers are climbing after a Food and Drug Administration advisory panel voted Thursday to add the peptide BPC-157 to a list that would permit broader pharmacy compounding. The vote came in at eight in favor, six against, with one abstention.","full_text":"Shares of Hims & Hers are climbing after a Food and Drug Administration advisory panel voted Thursday to add the peptide BPC-157 to a list that would permit broader pharmacy compounding. The vote came in at eight in favor, six against, with one abstention. Hims & Hers stock is up roughly 10%, trading around $34.78.\n- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions\n- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks\nPublished first on TheFly â the ultimate source for real-time, market-moving breaking financial news. Try Now>>\nRead More on HIMS:\n- Hims & Hers price target raised to $35 from $28 at Citi\n- Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 3.25%\n- Hims & Hers app downloads reverse 10 month decline, says Morgan Stanley\n- Hims & Hers Health Announces Accounting Officer Resignation\n- Hims & Hers chief accounting officer Irene Becklund to depart","reading_time_min":1,"extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 1024 characters.","diagnostics_url":"/api/diagnose?url=https%3A//www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 1024 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":1024,"summary_length":256,"usable_text_length":1024,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":1024,"summary_length":256}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 1024 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":1024,"summary_length":256,"usable_text_length":1024,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":1024,"summary_length":256}},"actions":{"read":"/item/46169","export_markdown":"/api/items/46169/export?format=markdown","export_json":"/api/items/46169/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news"}},"digest":{"id":46169,"title":"Hims & Hers rises after FDA advisers endorse broader BPC-157 access - TipRanks","url":"https://www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news","source":"TipRanks","topic":"peptides","published_at":"2026-07-23T17:13:58+00:00","excerpt":"Shares of Hims & Hers are climbing after a Food and Drug Administration advisory panel voted Thursday to add the peptide BPC-157 to a list that would permit broader pharmacy compounding. The vote came in at eight in favor, six against, with one abstention.","quality_bucket":"high","quality_reason":"High confidence: full text extraction produced 1024 characters.","reading_time_min":1,"cluster_id":null},"card":{"display_title":"Hims & Hers rises after FDA advisers endorse broader BPC-157 access - TipRanks","subtitle":"TipRanks · 2026-07-23","summary":"Shares of Hims & Hers are climbing after a Food and Drug Administration advisory panel voted Thursday to add the peptide BPC-157 to a list that would permit broader pharmacy compounding. The vote came in at eight in…","badges":["quality:high"],"links":{"read":"/item/46169","original":"https://www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news","diagnose":"/api/diagnose?url=https%3A//www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news"},"quality_warning":null},"export":{"title":"Hims & Hers rises after FDA advisers endorse broader BPC-157 access - TipRanks","url":"https://www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news","summary":"Shares of Hims & Hers are climbing after a Food and Drug Administration advisory panel voted Thursday to add the peptide BPC-157 to a list that would permit broader pharmacy compounding. The vote came in at eight in favor, six against, with one abstention.","source":"TipRanks","date":"2026-07-23T17:13:58+00:00","content":"Shares of Hims & Hers are climbing after a Food and Drug Administration advisory panel voted Thursday to add the peptide BPC-157 to a list that would permit broader pharmacy compounding. The vote came in at eight in favor, six against, with one abstention. Hims & Hers stock is up roughly 10%, trading around $34.78.\n- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions\n- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks\nPublished first on TheFly â the ultimate source for real-time, market-moving breaking financial news. Try Now>>\nRead More on HIMS:\n- Hims & Hers price target raised to $35 from $28 at Citi\n- Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 3.25%\n- Hims & Hers app downloads reverse 10 month decline, says Morgan Stanley\n- Hims & Hers Health Announces Accounting Officer Resignation\n- Hims & Hers chief accounting officer Irene Becklund to depart","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//www.tipranks.com/news/the-fly/hims-hers-rises-after-fda-advisers-endorse-broader-bpc-157-access-thefly-news","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 1024 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 1024 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":1024,"summary_length":256,"usable_text_length":1024,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":1024,"summary_length":256}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}